查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832308

生物可吸收聚合物市場（按產品、形式、製造流程、材料類型、應用和最終用戶分類）—2025-2032 年全球預測

Bioresorbable Polymers Market by Product, Form, Manufacturing Process, Material Type, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物可吸收聚合物市場將成長至 22.6558 億美元，複合年成長率為 10.78%。

主要市場統計數據
基準年2024年 9.9848億美元
預計2025年 1,101,030,000美元
預測年份：2032年 2,265,580,000美元
複合年成長率（%） 10.78%

生物可吸收聚合物是一類旨在在生物環境中安全分解的材料。聚合物化學和加工技術的最新進展使得精確調節分解速率、增強生物相容性以及實現兼具治療和結構功能的多功能結構成為可能。因此，這些材料正成為醫療設備、藥物傳輸和組織工程的關鍵推動力，而這些領域此前主要由永久性植入或不可分解系統主導。

同時，轉化科學正與先進製造技術融合，以生產纖維、薄膜、微粒和奈米級結構，拓展臨床醫生和產品開發者的設計視野。這些發展得到了越來越多的臨床前和臨床證據的支持，這些證據定義了安全性和性能基準。因此，相關人員現在正面臨一個關鍵時刻：隨著生物可吸收解決方案的技術相關性日益成熟，關鍵挑戰正轉向與法律規範的整合、供應鏈的穩健性和臨床可接受性。

這項技術的採用為深入探討材料類別、加工方法、特定應用要求以及策略行動奠定了基礎，旨在加速應用並降低營運風險。後續章節將全面說明技術變革、政策影響、細分市場資訊、地理變化、競爭定位，並為參與生物可吸收聚合物生態系統的組織提供實用建議。

聚合物化學、精密製造和臨床需求的進步如何融合，重新定義可吸收醫療材料的未來發展方向

材料創新、精密製造和跨領域合作正在改變生物可吸收聚合物的模式。在材料層面，新興材料正在提供可調控的分解性和功能基團相容性，超越傳統的聚乳酸體系，包括共聚物和專用骨架。這種不斷擴展的材料套件使開發人員能夠針對特定臨床情況（例如承重整形外科應用和精細的血管介入）最佳化機械性能和分解特性。

在製造業，積層製造和先進的成型技術正從原型製作轉向標準化生產，從而實現傳統方法無法實現的工程化支架和設備功能。這些工藝創新與材料科學相結合，正在降低變異性並提高可重複性。此外，為了滿足業界對一致性的期望，人們越來越重視可擴展的滅菌方法和「品質源自於設計」的典範。

臨床醫生越來越重視能夠減少二次手術和長期異物併發症的器械，這支持了人們對支架、固定裝置以及用於局部給藥的可吸收替代方案的興趣。此外，跨部門合作連接學術團體、臨床研究人員和行業開發者，透過整合專業知識、共用生物庫資源和轉化試驗網路，加速了轉化途徑。總而言之，這些轉變正在創造一個更模組化、循證且能夠可預測地將複雜的生物可吸收解決方案推向市場的生態系統。

評估2025年美國關稅變化對營運和供應鏈的調整及策略影響

政策和貿易環境對生物可吸收聚合物價值鏈產生了實際的影響，美國近期於2025年實施的關稅改變了中間原料、特殊聚合物和精密機械的進口動態。這些政策調整迫使製造商重新評估籌資策略，其直接影響集中在依賴國際原料流和進口擠出、射出成型和微加工設備資本財的供應商身上。

為了應對這項挑戰，一些製造商已實現供應基地多元化，或選擇在更靠近終端市場的地方進行合約製造，以緩解邊境相關不利因素。另一些製造商則加快了替代聚合物等級的認證或本地化供應商，以減輕關稅引發的成本波動的影響。累積的營運效應包括加強庫存管理、重新談判供應商合約以及加強對物流韌性的投資。雖然大型跨國生產商透過整合供應網路吸收了部分影響，但中小型生產商感受到了定價和前置作業時間的壓力，這影響了計劃進度和夥伴關係談判。

重要的是，這些關稅主導的調整也活性化了圍繞關鍵中間體垂直整合和加強國內生產力計畫的討論。有利於本地採購材料的監管調整和採購政策可以進一步影響採用軌跡。決策者必須評估供應商風險，保持靈活的籌資策略，並預測考慮潛在貿易政策波動的採購時間表。

深度細分觀點展示產品形式、製造路線、材料化學和應用的需求如何影響策略優先順序

細分分析透過考慮產品、形態、製造流程、材料類型、應用和最終用戶等維度，揭示出細微的商業機會和績效促進因素。沿著產品軸線評估時，此細分市場包括纖維、薄膜、微粒和奈米材料，每種材料都具有獨特的功能優勢：纖維提供定向強度和孔隙度控制，薄膜具有阻隔和舒適功能，微粒有助於實現可注射或可植入的藥物儲存，奈米材料則支持細胞層面的靶向相互作用。同時，形態因素（液體、粉末或固體）決定了處理方式、滅菌選項和合適的下游製造方法，從而影響解決方案可以進入哪些臨床工作流程。

製造流程包括吹塑成型、擠出和射出成型，每種製程都需要在產量、形狀複雜性和材料相容性之間進行權衡。設計人員選擇合適的製程來滿足器械的形態、規模和精度需求，同時要認知到製程引起的應力和熱歷史會對劣化行為產生顯著影響。聚酸酐、聚己內酯、Polyglycolic、聚羥基烷酯等化學材料可提供各種分解動力學和機械性能，以滿足特定的臨床需求。

藥物輸送系統，例如控制釋放製劑和特異性載體，利用可吸收基質來局部治療並最大限度地減少全身暴露。醫療植入，尤其是心血管支架和整形外科植入，利用臨時機械支撐，然後安全吸收，消除異物的長期存在。組織工程專注於支架設計和幹細胞支架來引導再生，而創傷治療裝置，例如黏合劑溶液和敷料，則利用臨時材料來促進修復。最後，最終用戶類別——生物技術公司、醫院診所、製藥公司和研究機構——正在透過不同的採購週期、監管預期和臨床部署路徑來塑造應用程式。這些細分有助於確定研發投資、製造能力和商業化策略的優先順序。

美洲、歐洲、中東和非洲以及亞太地區的區域動態正在影響監管途徑、製造地決策和臨床應用

地域因素在美洲、歐洲、中東和非洲以及亞太地區的技術採用、監管趨勢和供應鏈發展中發揮關鍵作用。在美洲，臨床界和報銷結構青睞能夠降低再治療和長期治療成本的創新，從而支持了人們對可吸收植入和局部給藥解決方案的興趣。法規環境強調安全性和臨床證據，鼓勵積極參與臨床試驗和機構合作，以加速轉化。

在歐洲、中東和非洲地區，一些國家的監管協調舉措和集中審查流程提供了更清晰的途徑，而另一些國家則要求提供全面的技術文件並承諾進行上市後監督。臨床偏好模式和採購機制也各不相同，主要企業根據每個地區制定打入市場策略。同樣，歐洲、中東和非洲地區的採購通常強調生命週期成本和臨床結果，從而強化了能夠顯著減少長期併發症的設備的價值提案。

亞太地區呈現出一個多元化但快速成熟的生態系統，擁有強大的製造能力和日益成長的臨床試驗活動。該地區的多個經濟體正在投資國內聚合物和醫療設備製造能力，為全球企業創造了競爭優勢和合作機會。亞太地區供應鏈的接近性縮短了區域製造商的前置作業時間，許多市場的監管現代化正在為新型可吸收解決方案創造清晰的臨床路徑。總而言之，這些區域動態推動著關於製造地、臨床夥伴關係和監管參與的決策，以最佳化產品應用和患者療效。

競爭格局概覽：現有企業、利基創新者和學術衍生企業如何制定其商業化和夥伴關係策略

生物可吸收聚合物的競爭格局呈現出以下特點：特種聚合物供應商、整合材料專業知識的設備製造商，以及主導於新型化學和結構的研究型新參與企業。現有企業利用其規模、檢驗的製造平台和監管經驗，致力於心血管和整形外科植入等高度合規的應用。這些現有企業通常強調品管系統、可追溯性和豐富的臨床資料集，以支持市場認可。

同時，規模較小的利基公司正在配方科學、先進製程和特定應用的調整方面做出創新貢獻。他們的敏捷性使他們能夠快速迭代材料混合和表面改性，以滿足尚未滿足的臨床需求。專業材料開發商和醫療設備製造商之間的合作日益普遍，促成了共同開發契約、許可協議和戰略夥伴關係關係，將材料特性與醫療設備功能相匹配。

此外，學術衍生公司和研究機構仍是顛覆性概念的重要來源，尤其是在刺激反應分解、多層次支架結構和生技藥品整合等領域。對於在這種競爭格局中生存的公司而言，關鍵的差異化優勢通常在於已證實的臨床效用、規模化生產能力以及清晰的監管環境。策略聯盟、有針對性的智慧財產權保護以及對生產合格的投資是將技術優勢轉化為商業性吸引力的審慎機制。

為高階主管提供可行的策略重點，將聚合物科學的進步轉化為可擴展、臨床檢驗和商業性可行的解決方案

為了加速價值實現，產業領導者應優先考慮一系列切實可行的行動，將科學前景與營運可行性結合。首先，投資於可靠的材料表徵和體內外相關性研究，以將分解特徵與性能終點聯繫起來。這些數據將減少監管的不確定性，並增強臨床醫生的信心。其次，推行模組化生產策略，使其能夠從中試規模擴展到商業化規模，同時保持對材料和製程的控制。

第三，我們透過多元化採購、與策略供應商合作以及關鍵中間體的本地生產來增強供應鏈的韌性，以緩解貿易政策和物流中斷的影響。與醫療保健系統合作建立註冊網路可以提供縱向數據，從而增強報銷能力。第五，我們培養跨職能團隊，在開發早期整合監管、臨床、生產和商業方面的專業知識，以避免後期返工，並使產品特性與應用促進要素保持一致。

最後，考慮透過許可、合資企業、共同開發契約等方式利用互補能力的智慧財產權策略和合作模式。透過同時實施這些建議，組織可以加快臨床時間，降低部署風險，並加強先進生物可吸收解決方案的商業性案例。

結合專家訪談、文獻綜合和比較技術評估的綜合方法確保了證據驅動、可操作的見解

本研究綜合報告也補充了對材料科學家、研發專業人員、臨床研究人員和供應鏈專家的初步訪談，以及對同行評審文獻和監管文件的系統性回顧。初步資訊旨在捕捉技術準備、生產限制、臨床偏好和採購考量。訪談主題透過跨資訊來源三角測量，以檢驗研究結果並識別趨同趨勢。

分析方法包括：根據特定應用的性能標準對材料類別進行比較評估，根據常見生產路線進行製程適用性評估，以及供應鏈中斷情境分析。強調交叉驗證，將開發商的技術聲明與獨立實驗室報告和臨床試驗註冊（如有）進行檢驗核對。監管考慮源自官方機構指南、產品認證和上市後監管摘要，以確保符合當前預期。

我們的研究方法優先考慮假設和資料來源的透明度。在切實可行的情況下，我們識別了研究的局限性和知識缺口，指南未來的研究，並為在生物可吸收聚合物領域考慮投資、合作和臨床項目的利益相關人員提供循證決策。

總結性結論強調了綜合實施在將生物可吸收聚合物創新轉化為持續臨床影響方面的關鍵作用

生物可吸收聚合物處於材料科學、臨床需求和製造能力的策略性交會點。化學、加工技術和協作轉化生態系統的進步降低了技術壁壘，並擴展了可行的臨床應用組合。然而，要充分發揮這些材料的潛力，需要在證據生成、供應鏈設計和監管參與方面採取審慎的行動，以確保其在規模化生產中一致的性能。

相關人員若能將嚴格的材料特性、可擴展的製造方法和有針對性的臨床證據項目結合，最有可能獲得臨床和經濟價值。政策動態、監管和採購實踐的地區差異進一步凸顯了製定本地化策略和靈活供應網路的必要性。最終，將科學創新與營運原則和策略夥伴關係關係相結合的組織將創造出最持久的採用途徑，提供以患者為中心的解決方案，從而減輕干預負擔並改善長期療效。

這個結論強調了一個現實的觀點：雖然技術準備已經很先進，但策略執行仍然是原型承諾和廣泛臨床影響之間的區別。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 可調分解速率的多層生物可吸收血管支架的研究進展
  • 將生物可吸收聚合物整合到藥物釋放型支架中以實現控制釋放曲線
  • 開發高強度生物可吸收整形外科固定裝置，減少二次手術
  • 擴大採用基於生物可吸收聚合物的手術網片，以盡量減少異物反應
  • 針對患者客製化的生物可吸收聚合物植入的新興積層製造
  • 監管協調對生物可吸收聚合物醫療設備核准時間的影響
  • 丙交酯-乙交酯共聚物配方的創新提高了機械完整性
  • 具有持續抗菌活性的生物可吸收聚合物傷口敷料的開發

第6章 2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章生物可吸收聚合物市場（按產品）

  • 纖維
  • 電影
  • 細顆粒
  • 奈米材料

9. 生物可吸收聚合物市場（依形態）

  • 液體
  • 粉末
  • 固體的

第 10 章。生物可吸收聚合物市場（依製造製程）

  • 吹塑成型
  • 擠壓
  • 射出成型

第 11 章生物可吸收聚合物市場（依材料類型）

  • 聚酸酐
  • 聚己內酯（PCL）
  • Polyglycolic（PGA）
  • 聚羥基烷酯（PHA）
  • 聚乳酸（PLA）

第12章生物可吸收聚合物市場（依應用）

  • 藥物輸送系統
    • 控制釋放製劑
    • 目標特異性載體
  • 醫療植入
    • 心血管支架
    • 整形外科植入
  • 組織工程
    • 骨架設計
    • 幹細胞支架
  • 創傷治療裝置
    • 黏合劑解決方案
    • 包紮材料

第 13 章生物可吸收聚合物市場（依最終使用者）

  • 生技公司
  • 醫院和診所
  • 製藥公司
  • 研究所

第14章生物可吸收聚合物市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 15 章。生物可吸收聚合物市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章生物可吸收聚合物市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Corbion NV
    • REVA Medical, LLC
    • Evonik Industries AG
    • Ashland Inc.
    • Poly-Med Incorporated
    • Zeus Industrial Products, Inc.
    • Foster Corporation
    • SEQENS SAS
    • Merck KGaA
    • Advanced Polymer Materials Inc.
Product Code: MRR-437D45957EE1

The Bioresorbable Polymers Market is projected to grow by USD 2,265.58 million at a CAGR of 10.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 998.48 million
Estimated Year [2025] USD 1,101.03 million
Forecast Year [2032] USD 2,265.58 million
CAGR (%) 10.78%

Bioresorbable polymers represent a class of materials engineered to degrade safely within biological environments while delivering functional performance during their intended service life. Recent advances in polymer chemistry and processing techniques have enabled precisely tuned degradation kinetics, enhanced biocompatibility, and multifunctional constructs that serve therapeutic and structural roles. As a result, these materials are emerging as critical enablers across medical devices, drug delivery, and tissue engineering, where permanent implants or nondegradable systems previously dominated.

Concurrently, translational science is converging with advanced manufacturing to produce architectures at the fiber, film, micro-particle, and nanoscale levels, expanding the design space for clinicians and product developers. These developments are supported by a growing corpus of preclinical and clinical evidence that clarifies safety profiles and performance benchmarks. Therefore, stakeholders now face a pivotal moment: the technical plausibility of bioresorbable solutions has matured, and the primary challenges shift toward integration with regulatory frameworks, supply chain robustness, and clinical acceptance.

This introduction sets the stage for a nuanced exploration of material classes, processing modalities, application-specific demands, and strategic actions that can accelerate adoption while mitigating operational risk. The succeeding sections synthesize technological shifts, policy impacts, segmentation intelligence, geographic variations, competitive positioning, and pragmatic recommendations for organizations engaged in the bioresorbable polymer ecosystem.

How advances in polymer chemistry, precision manufacturing, and clinical demand are converging to redefine the future pathways for resorbable medical materials

The landscape for bioresorbable polymers is undergoing transformative shifts driven by material innovation, precision manufacturing, and cross-disciplinary collaboration. At the material level, the palette of available chemistries has broadened beyond traditional polylactide systems to include copolymers and specialty backbones that afford tailored degradation and functional group compatibility. This expanded material toolkit enables developers to optimize mechanical properties and degradation profiles for specific clinical contexts, such as load-bearing orthopedic applications or delicate vascular interventions.

In manufacturing, additive and advanced molding techniques are moving from prototyping to regulated production, enabling architected scaffolds and device features previously unattainable with conventional methods. Such process innovation interacts with material science to reduce variability and enhance reproducibility, which in turn eases regulatory review pathways. Additionally, there is a growing emphasis on scalable sterilization approaches and quality-by-design paradigms that align with industry expectations for consistency.

Healthcare delivery trends are also reshaping demand: clinicians increasingly prioritize devices that reduce secondary procedures and long-term foreign body complications, which supports interest in resorbable alternatives for stents, fixation devices, and localized drug depots. Moreover, cross-sector collaborations-linking academic groups, clinical investigators, and industry developers-accelerate translational pathways by combining domain expertise, shared biobanking resources, and translational trial networks. Collectively, these shifts point toward an ecosystem that is more modular, evidence-driven, and capable of bringing complex bioresorbable solutions to market with improved predictability.

Assessment of the operational and supply chain adjustments prompted by United States tariff changes in 2025 and their strategic implications

Policy and trade environments have a tangible influence on the bioresorbable polymers value chain, and recent tariff measures introduced in the United States in 2025 altered import dynamics for intermediate feedstocks, specialty polymers, and precision equipment. These policy adjustments have prompted manufacturers to reassess sourcing strategies, with near-term effects concentrated on suppliers dependent on international raw-material flows or on capital goods imported for extrusion, injection molding, and microfabrication equipment.

In response, some manufacturers have diversified supply bases or engaged in contract manufacturing closer to end markets to mitigate border-related headwinds. Others have accelerated qualification of alternative polymer grades and localized suppliers to reduce exposure to tariff-induced cost volatility. The cumulative operational effect includes tighter inventory management, renegotiated supplier contracts, and increased investment in logistic resiliency. While larger multinational producers have absorbed a portion of the impact through integrated supply networks, smaller and mid-sized producers felt acute pricing and lead-time pressures that influenced project timelines and partnership negotiations.

Importantly, these tariff-driven adjustments also stimulated conversations around vertical integration for critical intermediates and enhanced domestic capacity planning. Regulatory alignment and procurement policies that favor locally supplied materials can further shape adoption pathways. For decision-makers, the key takeaway lies in evaluating supplier risk, maintaining flexible sourcing strategies, and anticipating procurement timelines that account for potential trade-policy volatility.

Deep segmentation perspective showing how product forms, manufacturing routes, material chemistries, and application demands inform strategic prioritization

Segmentation analysis reveals nuanced opportunities and performance drivers when examined across product, form, manufacturing process, material type, application, and end-user dimensions. When evaluated on the product axis, the field encompasses fibers, films, micro-particles, and nanomaterials, each offering distinct functional advantages: fibers provide directional strength and porosity control, films enable barrier and conformability functions, micro-particles facilitate injectable or implantable drug depots, and nanomaterials support targeted interactions at the cellular level. In parallel, the form factor-liquid, powder, or solid-dictates handling, sterilization choices, and suitable downstream fabrication approaches, influencing which clinical workflows a solution can enter.

Manufacturing processes span blow molding, extrusion, and injection molding, and each presents trade-offs among throughput, geometric complexity, and material compatibility. Designers select processes to match device geometry, scale, and precision needs, recognizing that process-induced stresses and thermal histories can materially affect degradation behavior. Material type remains a primary determinant of performance, with chemistries such as polyanhydrides, polycaprolactone, polyglycolic acid, polyhydroxyalkanoate, and polylactic acid offering diverse degradation kinetics and mechanical profiles that align with specific clinical demands.

Application-driven segmentation illustrates where value accrues: drug delivery systems, including controlled-release formulations and target-specific vehicles, exploit resorbable matrices to localize therapy and minimize systemic exposure. Medical implants, notably cardiovascular stents and orthopedic implants, leverage temporary mechanical support followed by safe resorption to eliminate long-term foreign body presence. Tissue engineering efforts focus on scaffold designs and stem cell scaffolding to guide regeneration, while wound healing devices such as adhesive solutions and bandaging materials use transient material presence to promote repair. Finally, end-user categories-biotechnology companies, hospitals and clinics, pharmaceutical companies, and research institutes-shape adoption through differing procurement cycles, regulatory expectations, and clinical deployment pathways. Together, these segmentation lenses inform prioritization of R&D investment, manufacturing capacity, and commercialization strategies.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping regulatory pathways, manufacturing footprint decisions, and clinical adoption

Geographic considerations play a significant role in technology adoption, regulatory trajectories, and supply chain architecture across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinical communities and reimbursement structures favor innovations that reduce repeat interventions and long-term care costs, which supports interest in resorbable implants and localized drug delivery solutions. The regulatory environment emphasizes safety and clinical evidence, prompting robust clinical trial engagement and institutional partnerships that can accelerate translation.

Across Europe, the Middle East & Africa, regulatory harmonization initiatives and centralized review processes in some jurisdictions facilitate pathway clarity but also require comprehensive technical documentation and post-market surveillance commitments. Clinical preference patterns and procurement mechanisms vary, leading companies to adopt regionally tailored market-entry strategies. Similarly, EMEA procurement often stresses lifecycle cost and clinical outcomes, reinforcing the value proposition of devices that demonstrably reduce long-term complications.

The Asia-Pacific region exhibits a heterogeneous but rapidly maturing ecosystem, with significant manufacturing capacity and growing clinical trial activity. Several economies in the region are investing in domestic polymer and medical-device capabilities, which creates both competitive advantages and collaborative opportunities for global players. Supply chain proximity in Asia-Pacific can reduce lead times for regional manufacturers, while regulatory modernization in many markets is creating clearer clinical pathways for novel resorbable solutions. Taken together, these regional dynamics inform decisions about manufacturing footprints, clinical partnerships, and regulatory engagements to optimize adoption and patient outcomes.

Competitive landscape insights highlighting how incumbents, niche innovators, and academic spinouts are shaping commercialization and partnership strategies

Competitive dynamics within the bioresorbable polymer landscape are characterized by a mix of specialty polymer suppliers, device manufacturers with integrated materials expertise, and research-driven entrants focused on novel chemistries or architected structures. Established firms leverage scale, validated manufacturing platforms, and regulatory experience to pursue high-compliance applications such as cardiovascular and orthopedic implants. These incumbents often emphasize quality management systems, traceability, and extensive clinical datasets to support market acceptance.

At the same time, smaller and niche players contribute innovation in formulation science, advanced processing, and application-specific adaptations. Their agility enables rapid iteration on material blends and surface modifications that can address unmet clinical needs. Collaboration between specialized material developers and device manufacturers is increasingly common, yielding co-development agreements, licensing arrangements, and strategic partnerships that align material properties with device function.

Furthermore, academic spin-outs and research institutes remain important sources of disruptive concepts, particularly in areas like stimulus-responsive degradation, hierarchical scaffold architectures, and integration of biologics. For organizations navigating this competitive landscape, differentiation often hinges on demonstrable clinical benefit, manufacturability at scale, and a clear regulatory strategy. Strategic alliances, targeted IP protection, and investments in manufacturing qualification are prudent mechanisms to convert technical advantage into commercial traction.

Actionable strategic priorities for executives to convert polymer science advancements into scalable, clinically validated, and commercially viable solutions

Industry leaders should prioritize a set of pragmatic actions that bridge scientific promise with operational execution to accelerate value realization. First, invest in robust materials characterization and in vitro-to-in vivo correlation studies that link degradation profiles to performance endpoints. Such data will reduce regulatory uncertainty and support clinician confidence. Second, pursue modular manufacturing strategies that allow scaling from pilot to commercial volumes while preserving material and process control; adopting quality-by-design principles can reduce variability and speed device qualification.

Third, develop supply chain resilience through diversified sourcing, strategic supplier partnerships, and where appropriate, localized production for critical intermediates to mitigate trade-policy or logistic disruptions. Fourth, structure clinical evidence generation to demonstrate meaningful patient outcomes and economic value; partnering with healthcare systems and forming registry networks can produce longitudinal data that reinforce reimbursement positions. Fifth, cultivate cross-functional teams that integrate regulatory, clinical, manufacturing, and commercial expertise early in development to avoid late-stage rework and to align product features with adoption drivers.

Finally, consider IP strategies and collaborative models that unlock complementary capabilities, whether through licensing, joint ventures, or co-development agreements. By executing these recommendations in parallel, organizations can reduce time-to-clinic, lower deployment risk, and strengthen the commercial case for advanced bioresorbable solutions.

Comprehensive methodology combining expert interviews, literature synthesis, and comparative technical evaluation to ensure evidence-based, actionable insights

This research synthesis integrates primary interviews with materials scientists, device developers, clinical investigators, and supply chain specialists, complemented by a systematic review of peer-reviewed literature and regulatory documentation. Primary inputs were structured to capture technology readiness, manufacturing constraints, clinical preferences, and procurement considerations. Interview themes were triangulated across sources to validate findings and identify convergent trends.

Analytical methods included comparative evaluation of material classes against application-specific performance criteria, process compatibility assessments for common manufacturing routes, and scenario analysis of supply chain disruptions. Emphasis was placed on cross-validation: technical claims from developers were checked against independent bench reports and clinical trial registries where available. Regulatory considerations were derived from public agency guidance, product clearances, and post-market surveillance summaries to ensure alignment with current expectations.

The research approach also prioritized transparency in assumptions and data provenance. Wherever practical, limitations and knowledge gaps are identified to guide future investigation and to support evidence-based decision-making by stakeholders considering investments, partnerships, or clinical programs in the bioresorbable polymers domain.

Concluding synthesis emphasizing the pivotal role of integrated execution in translating bioresorbable polymer innovations into durable clinical impact

Bioresorbable polymers occupy a strategic intersection of materials science, clinical need, and manufacturing capability. Advances in chemistries, processing technologies, and collaborative translational ecosystems have reduced technical barriers and expanded the portfolio of viable clinical applications. However, realizing the full potential of these materials requires deliberate action across evidence generation, supply chain design, and regulatory engagement to ensure consistent performance at scale.

Stakeholders that integrate rigorous materials characterization, scalable manufacturing practices, and targeted clinical evidence programs will be best positioned to capture clinical and economic value. Policy dynamics and regional differences in regulatory and procurement practices further emphasize the need for localized strategies and flexible supply networks. Ultimately, organizations that align scientific innovation with operational discipline and strategic partnerships will create the most durable pathways to adoption, delivering patient-centric solutions that reduce intervention burden and improve long-term outcomes.

This conclusion underscores a pragmatic view: technical readiness has advanced substantially, but strategic execution remains the differentiator between prototype promise and widespread clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advances in multi-layer bioresorbable vascular scaffolds with tunable degradation rates
  • 5.2. Integration of bioresorbable polymers in drug-eluting stents for controlled release profiles
  • 5.3. Development of high-strength bioresorbable orthopedic fixation devices reducing secondary surgeries
  • 5.4. Rising adoption of bioresorbable polymer-based surgical meshes to minimize foreign body reactions
  • 5.5. Emergence of additive manufacturing techniques for patient-specific bioresorbable polymer implants
  • 5.6. Regulatory harmonization impact on approval timelines for bioresorbable polymer medical devices
  • 5.7. Innovations in lactide-glycolide copolymer formulations improving mechanical integrity over time
  • 5.8. Development of bioresorbable polymer-based wound dressings with sustained antimicrobial activity

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioresorbable Polymers Market, by Product

  • 8.1. Fibers
  • 8.2. Films
  • 8.3. Micro-Particles
  • 8.4. Nanomaterials

9. Bioresorbable Polymers Market, by Form

  • 9.1. Liquid
  • 9.2. Powder
  • 9.3. Solid

10. Bioresorbable Polymers Market, by Manufacturing Process

  • 10.1. Blow Molding
  • 10.2. Extrusion
  • 10.3. Injection Molding

11. Bioresorbable Polymers Market, by Material Type

  • 11.1. Polyanhydrides
  • 11.2. Polycaprolactone (PCL)
  • 11.3. Polyglycolic Acid (PGA)
  • 11.4. Polyhydroxyalkanoate (PHA)
  • 11.5. Polylactic Acid (PLA)

12. Bioresorbable Polymers Market, by Application

  • 12.1. Drug Delivery Systems
    • 12.1.1. Controlled Release Formulations
    • 12.1.2. Target-Specific Vehicles
  • 12.2. Medical Implants
    • 12.2.1. Cardiovascular Stents
    • 12.2.2. Orthopedic Implants
  • 12.3. Tissue Engineering
    • 12.3.1. Scaffold Designs
    • 12.3.2. Stem Cell Scaffolding
  • 12.4. Wound Healing Devices
    • 12.4.1. Adhesive Solutions
    • 12.4.2. Bandaging Materials

13. Bioresorbable Polymers Market, by End-User

  • 13.1. Biotechnology Companies
  • 13.2. Hospitals and Clinics
  • 13.3. Pharmaceutical Companies
  • 13.4. Research Institutes

14. Bioresorbable Polymers Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Bioresorbable Polymers Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Bioresorbable Polymers Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Corbion NV
    • 17.3.2. REVA Medical, LLC
    • 17.3.3. Evonik Industries AG
    • 17.3.4. Ashland Inc.
    • 17.3.5. Poly-Med Incorporated
    • 17.3.6. Zeus Industrial Products, Inc.
    • 17.3.7. Foster Corporation
    • 17.3.8. SEQENS SAS
    • 17.3.9. Merck KGaA
    • 17.3.10. Advanced Polymer Materials Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIORESORBABLE POLYMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE BIORESORBABL